Research keywords (1)：
liver tumor, liver resection
Research theme for competitive and other funds (1)：
2021 - 2024 DKK1/CKAP4シグナルを標的とした肝細胞癌に対する新規抗癌治療の開発
Papers (129)：
Nobuaki Ishihara, Shohei Komatsu, Masahiro Kido, Hidetoshi Gon, Kenji Fukushima, Takeshi Urade, Toshihiko Yoshida, Keisuke Arai, Hiroaki Yanagimoto, Hirochika Toyama, et al. Complete response to tremelimumab plus durvalumab treatment in hepatocellular carcinoma with a bile duct tumor thrombus: A case report. Oncology letters. 2024. 28. 1. 332-332
AKIRA KOIZUMI, SHOHEI KOMATSU, SATOSHI OMIYA, YOSHIHIKO YANO, YOSHIMI FUJISHIMA, JUN ISHIDA, MASAHIRO KIDO, HIDETOSHI GON, KENJI FUKUSHIMA, TAKESHI URADE, et al. Current Roles of Ramucirumab in the Sequential Treatment of Unresectable Hepatocellular Carcinoma. Anticancer Research. 2024. 44. 5. 2055-2061
HIDETOSHI GON, SHOHEI KOMATSU, SATOSHI OMIYA, MASAHIRO KIDO, KENJI FUKUSHIMA, TAKESHI URADE, TOSHIHIKO YOSHIDA, KEISUKE ARAI, JUN ISHIDA, YOSHIHIDE NANNO, et al. The Albumin-bilirubin Grade as Prognostic Indicator for Recurrent Hepatocellular Carcinoma Needing Repeat Liver Resection. Anticancer Research. 2024. 44. 5. 2031-2038
Jun Ishida, Hirochika Toyama, Sadaki Asari, Tadahiro Goto, Yoshihide Nanno, Toshihiko Yoshida, Shinichi So, Takeshi Urade, Kenji Fukushima, Hidetoshi Gon, et al. Optimal cutoff values of drain amylase for predicting pancreatic fistula are different between open and laparoscopic distal pancreatectomy. Surgical endoscopy. 2024
